Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247. 0 ...

PERSPECTIVES The Roux-en-Y gastric bypass (RYGB) promotes better weight loss than laparoscopic sleeve gastrectomy (LSG) throughout a 5-year follow-up. Lower levels of total cholesterol, low-density ...

The significant weight loss following Roux-en-Y gastric bypass (RYGB) has been extensively reported 2. At first, it has been regarded as an effect of the diminishment in the volumetric capacity of the ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

Review Article Published: March 2007 Complications of antiobesity surgery Ninh T Nguyen & Samuel E Wilson Nature Clinical Practice Gastroenterology & Hepatology 4, 138–147 (2007) Cite this article ...

Although choledochoduodenostomy was widely performed for choledocholithiasis in the 1960s and 1970s, Roux-en-Y hepaticojejunostomy is currently the preferred biliary-enteric anastomosis for benign and ...